ID: ALA4648028

Max Phase: Preclinical

Molecular Formula: C14H18F3N5

Molecular Weight: 313.33

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N=C(NC(=N)NC1CCCC1)Nc1ccc(C(F)(F)F)cc1

Standard InChI:  InChI=1S/C14H18F3N5/c15-14(16,17)9-5-7-11(8-6-9)21-13(19)22-12(18)20-10-3-1-2-4-10/h5-8,10H,1-4H2,(H5,18,19,20,21,22)

Standard InChI Key:  YFWSJTMOYUOUCY-UHFFFAOYSA-N

Associated Targets(Human)

UMUC3 278 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T-24 2342 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A2780 11979 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HUVEC 11049 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 313.33Molecular Weight (Monoisotopic): 313.1514AlogP: 3.11#Rotatable Bonds: 2
Polar Surface Area: 83.79Molecular Species: BASEHBA: 2HBD: 5
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.44CX LogP: 3.24CX LogD: 0.04
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.43Np Likeness Score: -0.79

References

1. Xiao D, Lu Z, Wang Z, Zhou S, Cao M, Deng J, Hu X, Peng M, He C, Wu J, Xu S, Zhang H, Xu C, Wang W, Guan A, Yang X..  (2020)  Synthesis, biological evaluation and anti-proliferative mechanism of fluorine-containing proguanil derivatives.,  28  (2): [PMID:31864776] [10.1016/j.bmc.2019.115258]

Source